The University of California, Riverside is a public land-grant research university in Riverside, California. It is one of the ten campuses of the University of California system. The main campus sits on 1,900 acres in a suburban district of Riverside with a branch campus of 20 acres in Palm Desert.

During the past decade, University of California, Riverside conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 1 clinical trials were completed, i.e. on average, 9.1% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 1 clinical trials were completed. i.e. 12.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of California, Riverside" #1 sponsor was "University of California, Riverside" with 6 trials, followed by "California Pacific Medical Center Research Institute" with 1 trials sponsored, "Emalex Biosciences Inc." with 1 trials sponsored, "Jonsson Comprehensive Cancer Center" with 1 trials sponsored and "University of California, Irvine" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of California, Riverside" #1 collaborator was "National Institute on Aging (NIA)" with 3 trials as a collaborator, "University of California, Riverside" with 3 trials as a collaborator, "University of California, San Francisco" with 2 trials as a collaborator, "University of South Florida" with 2 trials as a collaborator and "American Psychological Foundation" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "University of California, Riverside" are "Aging" (2 trials), "Cognitive Change" (2 trials), "Hiv" (2 trials), "Anxiety Disorders" (1 trials) and "Atypical Parkinsonism" (1 trials). Many other conditions were trialed in "University of California, Riverside" in a lesser frequency.

Most popular intervention types in "University of California, Riverside" are "Behavioral" (7 trials), "Other" (4 trials) and "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Adult Broad Learning Experiment (ABLE)" (1 trials), "Behavioral Intervention" (1 trials), "Control Cognitive Training Program" (1 trials) and "Ecopipam" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of California, Riverside" are 10 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "University of California, Riverside". undefined are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in University of California, Riverside, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in University of California, Riverside, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 7 trials that are defined as “Not Applicable".